Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
52 participants
INTERVENTIONAL
2021-07-05
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis
NCT07174973
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
NCT02152085
Reducing Symptoms of Multiple Sclerosis Using Non-invasive Neuromodulation
NCT04498039
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS
NCT02606604
Effects of Vestibular Rehabilitation on MS-related Fatigue: a Randomized Control Trial
NCT01216137
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PT+ Device
PT plus translingual stimulation device PoNS device will be used to deliver trans-lingual electrical stimulation. The stimulation will be delivered while the participants engages in evidence-based physiotherapy for walking and balance.
PT plus translingual stimulation device
PoNS device will be used to deliver trans-lingual electrical stimulation. The stimulation will be delivered while the participants engages in evidence-based physiotherapy for walking and balance.
PT + Control Device
PT plus translingual stimulation control device Control device will be used. Participants will wear device while engaging in evidence-based physiotherapy for walking and balance.
PT plus translingual stimulation control device
Control device will be used. Participants will wear device while engaging in evidence-based physiotherapy for walking and balance.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PT plus translingual stimulation device
PoNS device will be used to deliver trans-lingual electrical stimulation. The stimulation will be delivered while the participants engages in evidence-based physiotherapy for walking and balance.
PT plus translingual stimulation control device
Control device will be used. Participants will wear device while engaging in evidence-based physiotherapy for walking and balance.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* gait deficit due to MS but still able to walk (EDSS less than 6.5, PDDS 3-6)
* older than 18 and less than 70 years of age
* agree to the study time commitment.
Exclusion Criteria
* currently already functional community ambulators (gait speed\>120cm/s)
* contra-indications to the use of translingual electrical stimulation (active or suspected malignant tumor; recent bleeding or open wounds in mouth; women who are pregnant, or sensitivity to nickel, gold or copper)
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial University of Newfoundland
OTHER
University of Saskatchewan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Donkers
Principal Investigator, Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Donkers
Role: PRINCIPAL_INVESTIGATOR
University of Saskatchewan
Michelle Ploughman
Role: PRINCIPAL_INVESTIGATOR
Memorial University of Newfoundland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial University of Newfoundland
St. John's, Newfoundland and Labrador, Canada
University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Bio 2578
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.